Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07543081 · ClinicalTrials.gov registry record · NA
Correcting Disinformation About Menthol Cigarettes and Flavored Cigars
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Not yet
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT07543081: Clinical Trial NA study, sponsored by Rutgers, The State University of New Jersey.
NCT07543081 is a NA study that has not yet begun recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07543081, a NA study, has not yet begun recruiting, sponsored by Rutgers, The State University of New Jersey.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.
Primary Outcome
Beliefs items address tobacco industry behaviors, including funding Black community organizations, paying Black lobbyists to oppose public health policies, and targeting Black and African American communities with menthol cigarette and flavored cigar marketing.
Interventions
- BEHAVIORAL Individual delivery of anti-disinformation messaging
- BEHAVIORAL Community delivery of anti-disinformation messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What is known before NCT07543081 opens enrollment
NCT07543081 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 2 interventions - of which Individual delivery of anti-disinformation messaging is the first listed.
NCT07543081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07543081 about?
NCT07543081 is a clinical study titled "Correcting Disinformation About Menthol Cigarettes and Flavored Cigars". Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.
What is the current status of trial NCT07543081?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2026-09-01. Estimated completion is 2028-01-31.
What interventions are being tested in trial NCT07543081?
The interventions under investigation include: Individual delivery of anti-disinformation messaging (BEHAVIORAL), Community delivery of anti-disinformation messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT07543081?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07543081's enrollment target sits among peer trials
1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI